Immucell Corporation reported preliminary unaudited sales results for the third quarter, nine months and Trailing twelve months ended September 30, 2023. For the quarter, the company reported total sales of $5.40 million against $4.80 million a year ago.

For the nine months, the company reported total sales of $12.38 million against $14.66 million a year ago.

For the Trailing twelve-months, the company reported $16.29 million against $20.10 million a year ago.